MANNKIND CORP Total Long-Term Debt
MANNKIND CORP (MNKD) had Total Long-Term Debt of $319.08 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Debt › Long-Term Debt, Unclassified
us-gaap:LongTermDebt · last filed 2026-08-05
- 2026-06-30: Long-term Debt $319.08M.
- 2026-03-31: Long-term Debt $318.72M.
- 2025-12-31: Long-term Debt $354.64M.
- 2025-09-30: Long-term Debt $109.65M.
| Period end | Long-term Debt |
|---|---|
| 2026-06-30 | $319.08M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $318.72M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $354.64M 10-K · filed 2026-02-26 |
| 2025-09-30 | $109.65M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $36.17M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $36.11M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $36.05M 10-K · filed 2026-02-26 |
| 2024-09-30 | $227.94M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $227.58M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $264.15M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $268.70M 10-K · filed 2025-02-26 |
| 2023-09-30 | $273.24M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $274.43M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $273.96M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $273.49M 10-K · filed 2024-02-27 |
| 2022-09-30 | $273.02M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $272.55M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $281.67M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $281.20M 10-K · filed 2023-02-23 |
| 2021-09-30 | $280.73M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $285.13M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $330.59M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $122.23M 10-K · filed 2022-02-24 |
| 2020-09-30 | $121.83M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $121.75M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $119.02M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $118.90M 10-K · filed 2021-02-25 |
| 2019-09-30 | $118.77M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $99.99M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $102.49M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $102.49M 10-K · filed 2020-02-25 |
| 2018-09-30 | $105.48M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $129.36M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $140.27M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $156.82M 10-Q · filed 2018-11-01 |
| 2015-09-30 | $185.40M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $244.90M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $232.50M 10-Q · filed 2015-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |